Galloping India Growth For Sacubitril/Valsartan Under Shadow Of Challenge

 
• By Anju Ghangurde

Sacubitril/valsartan combination sales surge in India driving growth in the cardiac care segment even as Novartis and challenger Natco slug it out in court over alleged patent infringement charges.  

Horses
Indian market for sacubitril/valsartan grows sharply • Source: Shutterstock

More from Business

More from Scrip